// App-Quantinova.ai

O12 : Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis

Researchers

Presenter

  • Elizabeth M A Hensor

Principal Investigators

  • Maya H Buch

  • Jennifer H Barrett

  • Jacqueline L Nam

  • Jane Freeston

  • Marco Colombo

  • Athina Spiliopoulou

  • Felix Agakov

  • Stephen Kelly

  • Myles J Lewis

  • Stephanie F Ling

  • Sebastien Viatte

  • Suzanne M M Verstappen

  • Anne Barton

  • Alexander J MacGregor

  • Costantino Pitzalis

  • Paul Emery

  • Philip G Conaghan

  • Ann W Morgan

Medical Centers

  • NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

  • Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom

  • Leeds Institute of Cancer and Pathology, School of Medicine, University of Leeds, Leeds, UNITED KINGDOM

  • Pharmatics Ltd, Pharmatics Ltd, Edinburgh, UNITED KINGDOM

  • Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Centre for Endocrinology, Queen Mary University of London, London, UK

  • Arthritis Research UK Centre for Genetics and Genomics, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UNITED KINGDOM

  • Arthritis Research UK Centre for Epidemiology Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester, United Kingdom

  • National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust, Manchester, UNITED KINGDOM

  • Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Infliximab

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A